NEUROMETRIX INC (NURO)

US6412558800 - Common Stock

4.44  +0.07 (+1.6%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

NEUROMETRIX INC

NASDAQ:NURO (5/1/2024, 7:13:28 PM)

4.44

+0.07 (+1.6%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap8.84M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NURO Daily chart

Company Profile

NeuroMetrix Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Waltham, Massachusetts and currently employs 27 full-time employees. The company went IPO on 2004-07-22. NeuroMetrix, Inc. is a commercial-stage neurotechnology company based in Woburn, Massachusetts. The firm is engaged in designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. The firm has two principal product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. The Company’s DPNCheck is its testing technology for peripheral neuropathies. The Company’s Quell is its wearable neuromodulation technology for chronic pain. The company refined approximately 200,000 chronic pain patients. Patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Company Info

NEUROMETRIX INC

1000 Winter Street

Waltham MASSACHUSETTS 01801

P: 17818909989

CEO: Shai N. Gozani

Employees: 27

Website: https://www.neurometrix.com/

NURO News

News Image13 days ago - NeuroMetrix, Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

NeuroMetrix today announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders....

News Imagea month ago - AB NewswireBeyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
News Image2 months ago - NeuroMetrix, Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that...

News Image2 months ago - NeuroMetrix, Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia

NeuroMetrix today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in Dec...

News Image2 months ago - NeuroMetrix, Inc.NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights

NeuroMetrix, Inc. today reported financial and business highlights for the quarter and full year ended December 31, 2023. ...

News Image3 months ago - NeuroMetrix, Inc.NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call

NeuroMetrix plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the market on February 22, 2024. ...

NURO Twits

Here you can normally see the latest stock twits on NURO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example